Market Tracker

05/26 5:16pm ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

6.46
Delayed Data
As of May 26
 +0.04 / +0.62%
Today’s Change
4.03
Today|||52-Week Range
7.80
+10.24%
Year-to-Date
No recent news for Keryx Biopharmaceuticals Inc.

Today’s Trading

Previous close6.42
Today’s open6.40
Day’s range6.38 - 6.53
Volume823,844
Average volume (3 months)1,409,111
Market cap$696.4M
Dividend yield--
Data as of 4:00pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-27.73%
Earnings growth (this year)+55.31%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+133.79%
P/E ratioNM
Price/Sales19.39
Price/Book--

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp-0.57-0.58%
MGNXMacroGenics Inc-0.71-3.74%
ADROAduro Biotech Inc-0.15-1.47%
CYTKCytokinetics Inc+0.05+0.36%
Data as of 4:00pm ET, 05/26/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$32.0M
Annual profit (last year)-$161.1M
Net profit margin-503.69%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Gregory P. Madison
Chief Operating Officer &
Senior Vice President
Christine A. Carberry
Corporate headquarters
Boston, Massachusetts

Forecasts